UB Paderborn / Katalog / Suche / in CDI

Sex differences in clinical outcomes in Japanese incident dialysis patients: a prospective observational multicenter study

Clinical and experimental nephrology, 2022-05, Vol.26 (5), p.466-475

2022

Link zum Volltext

Verfügbarkeit prüfen

Molecular Markers of Tubulointerstitial Fibrosis and Tubular Cell Damage in Patients with Chronic Kidney Disease

PloS one, 2015-08, Vol.10 (8), p.e0136994-e0136994

2015

Link zum Volltext

Verfügbarkeit prüfen

Sodium‐glucose cotransporter‐2 inhibitor luseogliflozin added to glucagon‐like peptide 1 receptor agonist liraglutide improves glycemic control with bodyweight and fat mass reductions in Japanese patients with type 2 diabetes: A 52‐week, open‐label, single‐arm study

Journal of diabetes investigation, 2018-03, Vol.9 (2), p.332-340

2018

Link zum Volltext

Verfügbarkeit prüfen

Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010

Clinical and experimental nephrology, 2013-04, Vol.17 (2), p.155-173

2013

Link zum Volltext

Verfügbarkeit prüfen

Influence of Renal Function on the 52-Week Efficacy and Safety of the Sodium Glucose Cotransporter 2 Inhibitor Luseogliflozin in Japanese Patients with Type 2 Diabetes Mellitus

Clinical therapeutics, 2016-01, Vol.38 (1), p.66-88.e20

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of the SGLT2 Inhibitor Luseogliflozin in Japanese Patients With Type 2 Diabetes Mellitus Stratified According to Baseline Body Mass Index: Pooled Analysis of Data From 52-Week Phase III Trials

Clinical therapeutics, 2016-04, Vol.38 (4), p.843-862.e9

2016

Link zum Volltext

Verfügbarkeit prüfen

Japan Renal Biopsy Registry: the first nationwide, web-based, and prospective registry system of renal biopsies in Japan

Clinical and experimental nephrology, 2011-08, Vol.15 (4), p.493-503

2011

Link zum Volltext

Verfügbarkeit prüfen

Fifty-two-week long-term clinical study of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise

Endocrine Journal, 2015, Vol.62(7), pp.593-603

2015

Link zum Volltext

Verfügbarkeit prüfen

Safety, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Luseogliflozin Dosing in Healthy Japanese Males: A Randomized, Single-Blind, Placebo-Controlled Trial

Advances in therapy, 2014-03, Vol.31 (3), p.345-361

2014

Link zum Volltext

Verfügbarkeit prüfen

Mineral Metabolism Markers Are Associated with Myocardial Infarction and Hemorrhagic Stroke but Not Ischemic Stroke in Hemodialysis Patients: A Longitudinal Study

PloS one, 2014-12, Vol.9 (12), p.e114678-e114678

2014

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of luseogliflozin added to various oral antidiabetic drugs in Japanese patients with type 2 diabetes mellitus

Journal of diabetes investigation, 2015-07, Vol.6 (4), p.443-453

2015

Link zum Volltext

Verfügbarkeit prüfen

Identification of MMP1 as a novel risk factor for intracranial aneurysms in ADPKD using iPSC models

Scientific reports, 2016-07, Vol.6 (1), p.30013-30013, Article 30013

2016

Link zum Volltext

Verfügbarkeit prüfen

Identification of multidrug and toxin extrusion (MATE1 and MATE2-K) variants with complete loss of transport activity

Journal of human genetics, 2009-01, Vol.54 (1), p.40-46

2009

Link zum Volltext

Verfügbarkeit prüfen

Fifty-two-week long-term clinical study of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise

ENDOCRINE JOURNAL, 2015-07, Vol.62 (7), p.593-603

2015

Link zum Volltext

Verfügbarkeit prüfen

Serial renal biopsy findings in a case of POEMS syndrome with recurrent acute renal failure

Clinical and experimental nephrology, 2012-02, Vol.16 (1), p.173-179

2012

Link zum Volltext

Verfügbarkeit prüfen

Durable hematological response and improvement of nephrotic syndrome on thalidomide therapy in a patient with refractory light chain deposition disease

International journal of hematology, 2011-05, Vol.93 (5), p.673-676

2011

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Strategy and the Role of Apheresis Therapy for ABO Incompatible Living Donor Liver Transplantation

Therapeutic apheresis and dialysis, 2005-08, Vol.9 (4), p.285-291

2005

Link zum Volltext

Verfügbarkeit prüfen

Correction: Activation of Src Mediates PDGF-Induced Smad1 Phosphorylation and Contributes to the Progression of Glomerulosclerosis in Glomerulonephritis

PloS one, 2012-09, Vol.7 (9)

2012

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, phase 3 study

Current medical research and opinion, 2014-07, Vol.30 (7), p.1245-1255

2014

Link zum Volltext

Verfügbarkeit prüfen

Amelioration of Murine Diabetic Nephropathy with a SGLT2 Inhibitor Is Associated with Suppressing Abnormal Expression of Hypoxia-Inducible Factors

The American journal of pathology, 2022-07, Vol.192 (7), p.1028-1052

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of luseogliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: a 12-week, randomized, placebo-controlled, phase II study

Current medical research and opinion, 2014-07, Vol.30 (7), p.1219-1230

2014

Link zum Volltext

Verfügbarkeit prüfen

P1373ERYTHROPOETIN RESISTANCE IN PRE-DIALYSIS PERIOD AND ITS RELATION TO PROGNOSIS IN JAPANESE INCIDENT DIALYSIS PATIENTS

Nephrology, dialysis, transplantation, 2020-06, Vol.35 (Supplement_3)

2020

Link zum Volltext

Verfügbarkeit prüfen

Low Density Lipoprotein Apheresis Ameliorates Interferon-γ Production in Patients With Nephrotic Syndrome

Therapeutic apheresis and dialysis, 2012-04, Vol.16 (2), p.189-194

2012

Link zum Volltext

Verfügbarkeit prüfen

The Role of Apheresis Therapy for ABO Incompatible Living Donor Liver Transplantation: The Kyoto University Experience

Therapeutic apheresis and dialysis, 2006-10, Vol.10 (5), p.441-448

2006

Link zum Volltext

Verfügbarkeit prüfen

Gender Difference in ICER Iγ Transgenic Diabetic Mouse

Bioscience, biotechnology, and biochemistry, 2007-08, Vol.71 (8), p.1920-1926

2007

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Sex differences in clinical outcomes in Japanese incident dialysis patients: a prospective observational multicenter study

Molecular Markers of Tubulointerstitial Fibrosis and Tubular Cell Damage in Patients with Chronic Kidney Disease

Sodium‐glucose cotransporter‐2 inhibitor luseogliflozin added to glucagon‐like peptide 1 receptor agonist liraglutide improves glycemic control with bodyweight and fat mass reductions in Japanese patients with type 2 diabetes: A 52‐week, open‐label, single‐arm study

Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010

Influence of Renal Function on the 52-Week Efficacy and Safety of the Sodium Glucose Cotransporter 2 Inhibitor Luseogliflozin in Japanese Patients with Type 2 Diabetes Mellitus

Efficacy and Safety of the SGLT2 Inhibitor Luseogliflozin in Japanese Patients With Type 2 Diabetes Mellitus Stratified According to Baseline Body Mass Index: Pooled Analysis of Data From 52-Week Phase III Trials

Japan Renal Biopsy Registry: the first nationwide, web-based, and prospective registry system of renal biopsies in Japan

Fifty-two-week long-term clinical study of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise

Safety, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Luseogliflozin Dosing in Healthy Japanese Males: A Randomized, Single-Blind, Placebo-Controlled Trial

Mineral Metabolism Markers Are Associated with Myocardial Infarction and Hemorrhagic Stroke but Not Ischemic Stroke in Hemodialysis Patients: A Longitudinal Study

Efficacy and safety of luseogliflozin added to various oral antidiabetic drugs in Japanese patients with type 2 diabetes mellitus

Identification of MMP1 as a novel risk factor for intracranial aneurysms in ADPKD using iPSC models

Identification of multidrug and toxin extrusion (MATE1 and MATE2-K) variants with complete loss of transport activity

Fifty-two-week long-term clinical study of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise

Serial renal biopsy findings in a case of POEMS syndrome with recurrent acute renal failure

Durable hematological response and improvement of nephrotic syndrome on thalidomide therapy in a patient with refractory light chain deposition disease

Therapeutic Strategy and the Role of Apheresis Therapy for ABO Incompatible Living Donor Liver Transplantation

Correction: Activation of Src Mediates PDGF-Induced Smad1 Phosphorylation and Contributes to the Progression of Glomerulosclerosis in Glomerulonephritis

Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, phase 3 study

Amelioration of Murine Diabetic Nephropathy with a SGLT2 Inhibitor Is Associated with Suppressing Abnormal Expression of Hypoxia-Inducible Factors

Efficacy and safety of luseogliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: a 12-week, randomized, placebo-controlled, phase II study

P1373ERYTHROPOETIN RESISTANCE IN PRE-DIALYSIS PERIOD AND ITS RELATION TO PROGNOSIS IN JAPANESE INCIDENT DIALYSIS PATIENTS

Low Density Lipoprotein Apheresis Ameliorates Interferon-γ Production in Patients With Nephrotic Syndrome

The Role of Apheresis Therapy for ABO Incompatible Living Donor Liver Transplantation: The Kyoto University Experience

Gender Difference in ICER Iγ Transgenic Diabetic Mouse

Aktive Filter

Suchergebnisse filtern